AEHR director trust sells 5,973 shares at $140
AEHR TEST SYSTEMS director Rhea J. Posedel, through a trust, reported selling 5,973 shares of common stock on 2026-08-14 in a sale described as an open market or private transaction at $140.00 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
AEHR TEST SYSTEMS director Rhea J. Posedel, through a trust, reported selling 5,973 shares of common stock on 2026-08-14 in a sale described as an open market or private transaction at $140.00 per share. After this sale, the trust holds 381,989 indirect shares, and a separate line shows 47,156 direct shares, which include shares subject to unvested restricted stock units.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 5,973 | $140.00 | $836K |
| holding | Common Stock F1 | -- | -- | -- |
Footnotes (1)
- F1. The amount reported includes shares subject to unvested restricted stock units.
Key Figures
Key Terms
indirect ownership financial
restricted stock units financial
open market or private transaction financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did AEHR (AEHR) report for Rhea J. Posedel?
What are Rhea J. Posedel’s direct AEHR (AEHR) holdings after the transaction?
Was the AEHR (AEHR) insider sale by Rhea J. Posedel made under a Rule 10b5-1 trading plan?
Is the AEHR (AEHR) sale by Rhea J. Posedel a direct or indirect ownership transaction?
AI-generated analysis. How Rhea-AI works. Not financial advice.